Wenmin Liu

3.7k total citations · 2 hit papers
103 papers, 3.0k citations indexed

About

Wenmin Liu is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Wenmin Liu has authored 103 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pharmacology, 26 papers in Molecular Biology and 21 papers in Organic Chemistry. Recurrent topics in Wenmin Liu's work include Cholinesterase and Neurodegenerative Diseases (24 papers), Computational Drug Discovery Methods (16 papers) and Alzheimer's disease research and treatments (13 papers). Wenmin Liu is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (24 papers), Computational Drug Discovery Methods (16 papers) and Alzheimer's disease research and treatments (13 papers). Wenmin Liu collaborates with scholars based in China, United Kingdom and United States. Wenmin Liu's co-authors include Changzhong Chen, Zhipei Sang, Keren Wang, Kelin Peng, Yafeng Guan, Zhenghuai Tan, Wanli Pan, Kun Xu, Hongwei Wang and Yiyang Zhao and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, ACS Catalysis and Environmental Pollution.

In The Last Decade

Wenmin Liu

96 papers receiving 3.0k citations

Hit Papers

Anxiety, depression, and stress prevalence among college ... 2021 2026 2022 2024 2021 2024 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenmin Liu China 31 665 642 608 435 390 103 3.0k
Vesna Vasić Serbia 28 719 1.1× 50 0.1× 1.2k 2.0× 993 2.3× 106 0.3× 118 4.5k
Jeongmi Lee South Korea 35 331 0.5× 233 0.4× 314 0.5× 1.4k 3.1× 112 0.3× 136 4.4k
Arun K. Sinha India 41 1.9k 2.8× 93 0.1× 247 0.4× 985 2.3× 1.3k 3.4× 203 5.9k
Na Zhu China 31 693 1.0× 301 0.5× 474 0.8× 602 1.4× 366 0.9× 178 4.4k
Longshan Zhao China 35 262 0.4× 154 0.2× 374 0.6× 1.4k 3.2× 171 0.4× 276 4.9k
Rui Jiao China 32 340 0.5× 116 0.2× 133 0.2× 712 1.6× 302 0.8× 123 3.0k
Xinmiao Liang China 33 1.2k 1.8× 159 0.2× 152 0.3× 844 1.9× 92 0.2× 147 4.3k
Zilin Chen China 44 311 0.5× 492 0.8× 264 0.4× 1.5k 3.5× 319 0.8× 294 8.1k
Yuzhong Liu China 22 321 0.5× 155 0.2× 275 0.5× 774 1.8× 736 1.9× 78 3.3k
Ana A. Matias Portugal 37 457 0.7× 178 0.3× 93 0.2× 525 1.2× 155 0.4× 82 3.5k

Countries citing papers authored by Wenmin Liu

Since Specialization
Citations

This map shows the geographic impact of Wenmin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenmin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenmin Liu more than expected).

Fields of papers citing papers by Wenmin Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenmin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenmin Liu. The network helps show where Wenmin Liu may publish in the future.

Co-authorship network of co-authors of Wenmin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenmin Liu. A scholar is included among the top collaborators of Wenmin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenmin Liu. Wenmin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yuting, Xinxin Wang, Zhengwei Liu, et al.. (2025). Development of novel rivastigmine derivatives as selective BuChE inhibitors for the treatment of AD. Bioorganic Chemistry. 157. 108245–108245. 3 indexed citations
2.
Ma, Qinge, et al.. (2025). Hepatoprotective Flavonolignan from Citrus medica var. sarcodactylis. Chemistry of Natural Compounds. 61(1). 37–41.
3.
Liu, Wenmin, et al.. (2025). Assessment of ecological asset quality and its drivers in Agro-pastoral Ecotone of China. Ecological Indicators. 170. 113072–113072. 2 indexed citations
4.
Si, Li, et al.. (2024). The reduced mortality of malignant melanoma at the population level is mainly attributable to treatment advances for the past decade. Cancer Epidemiology. 88. 102515–102515. 2 indexed citations
5.
Ji, Jiang, Yue An, Pengfei Ye, et al.. (2024). Angiotensin II type-2 receptor signaling facilitates liver injury repair and regeneration via inactivation of Hippo pathway. Acta Pharmacologica Sinica. 45(6). 1201–1213. 2 indexed citations
6.
Wang, Huiqing, Yaru Shang, Chade Lv, et al.. (2024). Boosting Carrier Separation on a BiOBr/Bi4O5Br2 Direct Z-Scheme Heterojunction for Superior Photocatalytic Nitrogen Fixation. ACS Catalysis. 14(8). 5779–5787. 89 indexed citations breakdown →
7.
Jin, Xiaoli, Qing Lan, Xin Li, et al.. (2023). Achieving high carrier separation over Bi4O5I2 through Ni doping for improved photocatalytic CO2 reduction. Nanotechnology. 34(40). 405201–405201. 2 indexed citations
8.
Liu, Wenmin, Tianpei Wang, Meng Zhu, & Guangfu Jin. (2023). Healthy Diet, Polygenic Risk Score, and Upper Gastrointestinal Cancer Risk: A Prospective Study from UK Biobank. Nutrients. 15(6). 1344–1344. 13 indexed citations
9.
Zhou, Yi, Ying He, Jing Mi, et al.. (2023). Development of novel salicylic acid–donepezil–rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2231661–2231661. 8 indexed citations
10.
Liu, Wenmin & Xinxin Liu. (2021). LINC00641 Inhibits the Development of Cutaneous Squamous Cell Carcinoma By Downregulating miR-424 in A431 Cells. Cancer Biotherapy and Radiopharmaceuticals. 39(7). 532–540. 6 indexed citations
11.
Wang, Keren, Jian Shi, Yi Zhou, et al.. (2021). Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer’s disease. Bioorganic Chemistry. 112. 104879–104879. 24 indexed citations
12.
Sang, Zhipei, Keren Wang, Ping Bai, et al.. (2020). Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry. 194. 112265–112265. 37 indexed citations
13.
Sang, Zhipei, Keren Wang, Jian Shi, Wenmin Liu, & Zhenghuai Tan. (2019). Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 178. 726–739. 48 indexed citations
14.
Wang, Yuan, et al.. (2019). A novel indicator, childhood lipid accumulation product, is associated with hypertension in Chinese children and adolescents. Hypertension Research. 43(4). 305–312. 10 indexed citations
15.
Wei, Rongrui, Qinge Ma, Tao Li, et al.. (2018). Carbazole alkaloids with antiangiogenic activities from Clausena sanki. Bioorganic Chemistry. 77. 387–392. 11 indexed citations
16.
Zhang, Sheng, Lijun Li, Huiqiao Wang, et al.. (2017). Scalable Electrochemical Dehydrogenative Lactonization of C(sp2/sp3)–H Bonds. Organic Letters. 20(1). 252–255. 143 indexed citations
18.
Ma, Qinge, Kun Xu, Zhipei Sang, et al.. (2015). Alkenes with antioxidative activities from Murraya koenigii (L.) Spreng. Bioorganic & Medicinal Chemistry Letters. 26(3). 799–803. 33 indexed citations
19.
Liu, Wenmin, et al.. (2005). Physically incorporated extraction phase of solid-phase microextraction by sol–gel technology. Journal of Chromatography A. 1102(1-2). 37–43. 34 indexed citations
20.
Wang, Hanwen, Wenmin Liu, & Yafeng Guan. (2004). In-tube solid-phase microextraction and on-line coupling with high-resolution GC. LCGC North America. 22(1). 16–24. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026